LAG3 and neoplasm: Since LAG-3 is often co-expressed with PD-1 on tumor-infiltrating lymphocytes [42, 43], it has been proposed that blockade of LAG-3 in conjunction with blockade of PD-1 could be promising to increase treatment response [26, 44].